for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BioNTech SE - ADR

22UAy.DE

Latest Trade

233.50EUR

Change

6.00(+2.64%)

Volume

161,071

Today's Range

227.50

 - 

235.10

52 Week Range

65.50

 - 

395.00

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

EMA Starts Evaluating Use Of COVID-19 Vaccine Comirnaty In Children Aged 5 To 11

Oct 18 (Reuters) - European Medicines Agency::EMA: EMA STARTS EVALUATING USE OF COVID-19 VACCINE COMIRNATY IN CHILDREN AGED 5 TO 11: 18/10/2021.EMA SAYS EMA HAS STARTED EVALUATING AN APPLICATION TO EXTEND USE OF BIONTECH/PFIZER'S COVID-19 VACCINE, COMIRNATY, TO CHILDREN AGED 5 TO 11 .EMA SAYS CHMP WILL REVIEW DATA ON VACCINE, INCLUDING RESULTS FROM AN ONGOING CLINICAL STUDY INVOLVING CHILDREN AGED 5 TO 11 . ((Reuters.Briefs@thomsonreuters.com;)).

Pfizer And Biontech Submit Data To EMA For Vaccination Of Children 5 To <12 Years Of Age With Comirnaty

Oct 15 (Reuters) - PFIZER::PFIZER AND BIONTECH SUBMIT DATA TO EMA FOR VACCINATION OF CHILDREN 5 TO <12 YEARS OF AGE WITH COMIRNATY.PFIZER - DATA FOR THE VACCINATION OF CHILDREN 5 TO <12 YEARS OF AGE WITH COMIRNATY WILL BE FILED WITH OTHER REGULATORY AUTHORITIES IN THE COMING WEEKS.PFIZER INC - VARIATION REQUEST INCLUDES DATA FROM A PHASE 2/3 STUDY, WHICH IS ENROLLING CHILDREN 6 MONTHS TO <12 YEARS OF AGE.Further company coverage: [22UAy.DE]. ((Reuters.Briefs@thomsonreuters.com;)).

Pfizer Says Co And Biontech Officially Submitted Request To FDA For Authorization Of COVID-19 Vaccine In Children 5 To <12 - Tweet

Oct 7 (Reuters) - :PFIZER SAYS CO AND BIONTECH OFFICIALLY SUBMITTED REQUEST TO FDA FOR EMERGENCY USE AUTHORIZATION OF OUR COVID19 VACCINE IN CHILDREN 5 TO <12 - TWEET.Further company coverage: [22UAy.DE]. ((Reuters.Briefs@thomsonreuters.com;)).

Pfizer Says EMA Gave Positive Opinion On Administration Of Covid-19 Vaccine As Booster Dose At Least 6 Months After Second Dose In 18 Years Of Age,Older

Oct 4 (Reuters) - Pfizer::PFIZER AND BIONTECH RECEIVE CHMP POSITIVE OPINION FOR COVID-19 VACCINE BOOSTER IN THE EUROPEAN UNION.PFIZER - EMA GAVE POSITIVE OPINION ON ADMINISTRATION OF COVID-19 VACCINE AS BOOSTER DOSE AT LEAST 6 MONTHS AFTER SECOND DOSE IN 18  YEARS OF AGE,OLDER.PFIZER - EC WILL REVIEW CHMP RECOMMENDATION, EXPECTED TO MAKE A FINAL DECISION ON A VARIATION TO CONDITIONAL MARKETING AUTHORIZATION IN NEAR FUTURE.PFIZER - DO NOT EXPECT INTRODUCTION OF BOOSTER DOSES IN UNITED STATES AND EU, IF AUTHORIZED, TO IMPACT EXISTING SUPPLY AGREEMENTS.

Pfizer And Biontech Get CHMP Positive Opinion For COVID-19 Vaccine Booster In EU

Oct 4 (Reuters) - BIONTECH SE <22UAy.DE>::PFIZER AND BIONTECH RECEIVE CHMP POSITIVE OPINION FOR COVID-19 VACCINE BOOSTER IN THE EUROPEAN UNION.EUROPEAN COMMISSION (EC) WILL REVIEW CHMP RECOMMENDATION AND IS EXPECTED TO MAKE A FINAL DECISION ON A VARIATION TO CONDITIONAL MARKETING AUTHORIZATION IN NEAR FUTURE.

Pfizer’S Covid-19 Vaccine For Kids May Not Be FDA Authorized Before November - WSJ

Sept 28 (Reuters) - :PFIZER’S COVID-19 VACCINE FOR KIDS MAY NOT BE FDA AUTHORIZED BEFORE NOVEMBER - WSJ.Further company coverage: PFE.N. ((Reuters.Briefs@thomsonreuters.com;)).

Uk's MHRA Says Vaccine Shelf Life For Pfizer COVID-19 Vaccine Extended From 6 Months To 9 Months

Sept 27 (Reuters) - UK's Medicines and Healthcare products Regulatory Agency::UK'S MHRA - EXTENDED VACCINE SHELF LIFE FOR PFIZER COVID-19 VACCINE FROM 6 MONTHS TO NOW 9 MONTHS..Further company coverage: PFE.N. ((Reuters.Briefs@thomsonreuters.com;)).

CDC Statement On ACIP Booster Recommendations

Sept 24 (Reuters) - :CDC STATEMENT ON ACIP BOOSTER RECOMMENDATIONS.CDC SAYS CDC DIRECTOR ENDORSED ACIP RECOMMENDATION FOR BOOSTER SHOT OF PFIZER-BIONTECH COVID-19 VACCINE IN CERTAIN POPULATIONS.CDC RECOMMENDS PEOPLE 65 YEARS AND OLDER&RESIDENTS IN LONG-TERM CARE SETTINGS SHOULD RECEIVE BOOSTER SHOT ATLEAST 6 MONTHS AFTER THEIR PRIMARY SERIES.CDC- RECOMMENDS PEOPLE AGED 50–64 YEARS WITH UNDERLYING MEDICAL CONDITIONS SHOULD RECEIVE BOOSTER SHOT OF PFIZER-BIONTECH’S COVID-19 VACCINE AT LEAST 6 MONTHS AFTER THEIR PFIZER-BIONTECH PRIMARY SERIES.CDC- RECOMMENDS PEOPLE AGED 18–49 YEARS WITH UNDERLYING MEDICAL CONDITIONS MAY RECEIVE BOOSTER SHOT OF PFIZER-BIONTECH’S COVID-19 VACCINE AT LEAST 6 MONTHS AFTER THEIR PFIZER-BIONTECH PRIMARY SERIES, BASED ON THEIR INDIVIDUAL BENEFITS AND RISKS.CDC-RECOMMENDS PEOPLE AGED 18-64 YEARS, AT INCREASED RISK FOR COVID19 EXPOSURE&TRANSMISSION BECAUSE OF OCCUPATIONAL OR INSTITUTIONAL SETTING,MAY RECEIVE BOOSTER SHOT OF PFIZER-BIONTECH’S COVID-19 VACCINE ATLEAST 6MONTHS AFTER PRIMARY SERIES.

FDA Says Authorizes Booster Dose Of Pfizer-Biontech Covid-19 Vaccine For Certain Populations

Sept 22 (Reuters) - FDA: :FDA SAYS AUTHORIZES BOOSTER DOSE OF PFIZER-BIONTECH COVID-19 VACCINE FOR CERTAIN POPULATIONS.FDA SAYS AUTHORIZES BOOSTER DOSE OF PFIZER-BIONTECH COVID-19 VACCINE FOR INDIVIDUALS 65 YEARS OF AGE AND OLDER.FDA SAYS AUTHORIZES BOOSTER DOSE OF PFIZER-BIONTECH COVID-19 VACCINE FOR INDIVIDUALS 18 THROUGH 64 YEARS OF AGE AT HIGH RISK OF SEVERE COVID-19.FDA SAYS AUTHORIZES BOOSTER DOSE OF PFIZER-BIONTECH COVID-19 VACCINE FOR INDIVIDUALS 18 THROUGH 64 YEARS OF AGE THAT PUTS THEM AT HIGH RISK. ((Reuters.Briefs@thomsonreuters.com;)).

Pfizer Inc And Biontech Expand Collaboration With U.S. To Provide Covid-19 Vaccine Doses At Not-For-Profit Price For Donation To Poorest Countries

Sept 22 (Reuters) - Pfizer Inc <PFE.N>::PFIZER AND BIONTECH EXPAND COLLABORATION WITH U.S. TO PROVIDE 500 MILLION ADDITIONAL COVID-19 VACCINE DOSES AT NOT-FOR-PROFIT PRICE FOR DONATION TO POOREST COUNTRIES.PFIZER INC - EXPANDED AGREEMENT BRINGS TOTAL NUMBER OF COVID-19 VACCINE DOSES TO BE SUPPLIED TO U.S. GOVERNMENT FOR DONATION TO ONE BILLION.PFIZER INC - PFIZER AND BIONTECH HAVE SHIPPED MORE THAN 1.5 BILLION COVID-19 VACCINE DOSES WORLDWIDE.PFIZER INC - EXPANDED AGREEMENT BRINGS TOTAL NUMBER OF DOSES TO BE SUPPLIED TO U.S. GOVERNMENT FOR DONATION TO THESE COUNTRIES TO ONE BILLION.PFIZER INC - OVERALL, PFIZER AND BIONTECH HAVE SHIPPED MORE THAN 1.5 BILLION COVID-19 VACCINE DOSES WORLDWIDE.PFIZER INC - CURRENT PLAN IS TO PRODUCE DOSES IN PFIZER'S U.S. FACILITIES LOCATED IN KALAMAZOO, MI, ANDOVER, MA, CHESTERFIELD, MO, AND MCPHERSON, KS.PFIZER INC - TOTAL ONE BILLION DOSES UNDER EXPANDED AGREEMENT ARE EXPECTED TO BE DELIVERED BY END OF SEPTEMBER 2022.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up